PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | C0019163|hepatitis b |
| Sentences | 50 |
| PubMedID- 21191876 | [low response rate to a vaccination against hepatitis b in patients with end-stage liver disease]. |
| PubMedID- 22681852 | Although several chronic liver diseases are associated with hcc, hepatitis b virus (hbv) and hepatitis c virus (hcv) statistically are the most commonly implicated risk factors. |
| PubMedID- 23637498 | The present study was designed to investigate the distribution of genotypes and its association with severity of liver disease in patients with chronic hepatitis b (chb) in uttar pradesh, india. |
| PubMedID- 23252849 | Specific mutations of basal core promoter are associated with chronic liver disease in hepatitis b virus subgenotype d1 prevalent in turkey. |
| PubMedID- 22989301 | Background and aim: non-alcoholic fatty liver disease (nafld) overlapping with chronic hepatitis b virus (hbv) infection is undergoing a rapid increase in china. |
| PubMedID- 22537436 | Noninvasive methods to assess liver disease in patients with hepatitis b or c. |
| PubMedID- 24005956 | Key exclusion criteria included: (1) presence of liver cirrhosis or hepatic failure, or other liver disease, (2) infection/co-infection with hiv-1, hiv-2, hepatitis b or nongenotype 1 hcv, (3) malignant tumor within 5 years prior to study, (4) hcc, (5) meeting conditions that required caution with pegifnα-2a or rbv treatment, (6) any clinically significant disease, (7) organ transplant, and (8) defined laboratory abnormalities during screening. |
| PubMedID- 26300933 | hepatitis b can lead to serious liver diseases, including cirrhosis, liver cancer. |
| PubMedID- 21055694 | Morphologic aspects of liver disease associated with hepatitis b and c viruses, autoimmune hepatitis, and hiv infection were addressed, as was the prevalent problem of nonalcoholic fatty liver disease. |
| PubMedID- 24403913 | Measured nine serum fibrosis markers including tissue inhibitor of metalloproteinase 1 (timp-1), tenascin-c, piiinp, laminin, matrix metalloproteinase-2 and 9, collagen type iv, collagen type vi and hyaluronan to predict advanced liver disease in patients with chronic hepatitis b. they observed that levels of timp1 and ha and finally their combination are powerful markers amongst other measured serum fibrosis markers to be used instead of a liver biopsy (10). |
| PubMedID- 23146778 | All articles that provided enough information to estimate the chronic liver disease risk associated with occult hepatitis b virus infection were selected. |
| PubMedID- 26112990 | Interactions of hepatitis b virus infection with nonalcoholic fatty liver disease: possible mechanisms and clinical impact. |
| PubMedID- 22141390 | This article reviews the clinical efficacy and tolerability of entecavir in the treatment of chronic hepatitis b in patients with decompensated liver disease, as well as summarizing its pharmacological properties. |
| PubMedID- 22980664 | [expression of mcp-1 in the patients of chronic hepatitis b complicated with nonalcoholic fatty liver disease]. |
| PubMedID- 21254162 | Data are limited on the safety and effectiveness of oral antivirals other than lamivudine and adefovir dipivoxil for treatment of chronic hepatitis b (chb) in patients with decompensated liver disease. |
| PubMedID- 23923056 | Background and goals: hepatitis a (hav) and hepatitis b (hbv) vaccination in patients with chronic liver disease is an accepted standard of care. |
| PubMedID- 23626552 | In older patients, common predisposing conditions include cirrhosis in general, and in particular chronic liver disease associated with persistent hepatitis b and c infection. |
| PubMedID- 22012714 | The virologic determinants of progressive liver disease associated with hepatitis b virus (hbv) remain unclear. |
| PubMedID- 26226455 | liver disease associated with persistent hepatitis b virus (hbv) infection represents a major health problem with global impact. |
| PubMedID- 21331379 | Tlr-mediated signals result in liver disease associated with hepatitis b, hepatitis c, alcoholicnonalcoholic steatohepatitis, and hepatic fibrosis [19]. |
| PubMedID- 22798114 | Methods: the study enrolled 94 chronic hepatitis b patients with compensated liver disease. |
| PubMedID- 23801844 | Aim: to evaluate psychometrics of the chinese (mainland) chronic liver disease questionnaire (cldq) in patients with chronic hepatitis b (chb). |
| PubMedID- 26045709 | Saturated fatty acid inhibits viral replication in chronic hepatitis b virus infection with nonalcoholic fatty liver disease by toll-like receptor 4-mediated innate immune response. |
| PubMedID- 26294919 | Initial findings revealed that human bm-mscs were able to improve liver function in hepatitis b patients with end-stage liver disease [45]. |
| PubMedID- 20840785 | Hdl and adiponectin share common metabolic pathways, however, their role in liver diseases associated with chronic hepatitis b infection is not well understood. |
| PubMedID- 24651854 | Importantly, similar m2-like macrophage accumulation was confirmed in chronic hepatitis b patients with liver diseases. |
| PubMedID- 24693307 | Non-invasive histologic markers of liver disease in patients with chronic hepatitis b. |
| PubMedID- 25216239 | liver diseases were mostly attributed to hepatitis b virus infection (34%). |
| PubMedID- 24768454 | The leading causes of chronic liver disease associated with hcc are hepatitis b and c viruses throughout the world, and alcohol and nash in france. |
| PubMedID- 24665160 | The study evaluated the frequency of hepatitis b and c in patients with chronic liver disease and correlated the levels of serum alpha-fetoprotein with hepatitis b and c infection in the patients. |
| PubMedID- 26201622 | Nafld seems to be related to host metabolic factors rather than viral factors and does not seem to affect severity of the liver disease in patients with chronic hepatitis b. |
| PubMedID- 23324345 | Hepatic fibrosis results from many chronic liver diseases, including hepatitis b virus (hbv), hepatitis c virus (hcv), alcoholic liver disease and non-alcoholic steatohepatitis (nash).1 hepatic fibrosis is the scar caused by deregulation of physiological wound healing and results in excessive production of extracellular matrix (ecm), mostly collagen type i. myofibroblasts, which are not present in normal liver, are the major source of the ecm during fibrogenesis. |
| PubMedID- 21194431 | The underlying etiology of liver disease was attributed to hepatitis b virus (hbv) infection if patients were seropositive for hepatitis b surface antigen (hbsag, ria kits, abbott laboratories, north chicago, il, usa) and attributed to hepatitis c virus (hcv) infection if patients were seropositive for an antibody against hcv by a second-generation enzyme immunoassay (abbott laboratories, il). |
| PubMedID- 24470860 | hepatitis b can lead to liver diseases ranging from the acute hepatitis to chronic hepatitis, cirrhosis and hepatocellular carcinoma (hcc) (1-2). |
| PubMedID- 23551989 | The association between circulating oestradiol levels and severity of liver disease in males with hepatitis b virus infection. |
| PubMedID- 23451126 | Further, we excluded trials on vaccination for prevention of hepatitis b recurrence due to hbv-related liver disease, transplant recipients with a history of hbv infection or anti-hbc positive grafts. |
| PubMedID- 20932622 | Of these, chronic liver disease resulting from hepatitis b or c virus infection has been reported as a secondary cause of iga nephropathy. |
| PubMedID- 20461127 | [18], francetwo double-blind, placebo controlled trials to investigate the safety and tolerability of two dosing regimens of adv (10 mg daily or 30 mg daily), 48-wk follow-up.n = 515 in the 10-mg study and 185 in the 30-mg study, chronic hepatitis b patients with compensated liver disease not undergoing treatment with evidence of viral replication.no overall median change from baseline in serum creatinine or phosphorus levels in 10 mg group. |
| PubMedID- 26469342 | Exclusion criteria included evidence of alcoholic liver disease and co-infection with hepatitis b and hepatitis c. age, gender, height, weight, body mass index (bmi), serum aspartate aminotransferase (ast), alanine aminotransferase (alt), total bilirubin and platelet counts were recorded, and apri scores were calculated at the time of histopathological examination. |
| PubMedID- 25208465 | liver diseases were mostly attributed to hepatitis b virus infection (32%). |
| PubMedID- 25578311 | Platelets are key elements in the pathogenesis of acute and chronic liver disease associated with hepatitis b virus (hbv) infection by promoting the accumulation of virus-specific cd8(+) t cells and nonspecific inflammatory cells into the liver parenchyma. |
| PubMedID- 26246574 | More than 500,000 people die each year from the liver diseases that result from chronic hepatitis b virus (hbv) infection. |
| PubMedID- 25532128 | The mechanisms whereby hdv leads to accelerated liver disease in hepatitis b virus (hbv)/hdv co-infected patients and the histological characteristics of chronic hepatitis d (chd) patients need further investigation. |
| PubMedID- 21415769 | Background: hepatitis b leads to chronic liver disease, cirrhosis, and hepatocellular cancer. |
| PubMedID- 24072155 | hepatitis b infection is associated with progressive liver disease and diminished survival in kidney transplant recipients. |
| PubMedID- 25663852 | In the majority of cases, hcc originates from chronic liver diseases, mainly with progression from hepatitis b virus (hbv) and hepatitis c virus (hcv) to cirrhosis in asian populations. |
| PubMedID- 23622604 | There is an extremely high burden of liver disease owing to viral hepatitis b (hbv); about 2 billion people are infected and 350 million are chronic carriers of hbv worldwide. |
| PubMedID- 26384610 | To determine the threshold value for identifying chronic liver disease, 29 patients with chronic hepatitis b who underwent liver biopsy, including patients without fibrosis (fibrosis stage f0; n = 9) and patients with substantial fibrosis (f1-f2; n = 20) were also investigated. |
| PubMedID- 22371770 | Most hccs are associated with chronic liver diseases resulting from hepatitis b or c viral infection, and the processes of chronic inflammation and fibrosis act as a stressful condition. |
| PubMedID- 24155775 | Therefore, it is a major global health problem 1-5. most cases of hcc are attributable to chronic liver disease resulting from chronic hepatitis b virus (hbv) and hepatitis c virus (hcv) infection 1-5. a recent report by chung et al. |
Page: 1